TY  - JOUR
T1  - Genetic testing for cancer risk: How to reconcile the conflicts
AU  - Kodish E, Wiesner GL, Mehlman M, Murray T
Y1  - 1998/01/21
N1  - 10.1001/jama.279.3.179
JO  - JAMA
SP  - 179
EP  - 181
VL  - 279
IS  - 3
N2  - 
Recent policy directives, which conflict with one another, reflect the
promise and the peril of this cancer genetics technology. In this article,
using breast cancer predisposition testing as an example, we describe 3 such
statements from organizations selected because they represent researchers,
oncologists, and consumers. Because practicing clinicians will encounter patients
who request testing, we conclude with suggestions to help clinicians understand
these conflicting positions and respond to patients.

SN  - 0098-7484
M3  - doi: 10.1001/jama.279.3.179
UR  - http://dx.doi.org/10.1001/jama.279.3.179
ER  -